Foundayo: What the First Oral GLP-1 Weight-Loss Pill Means for Your Health
Foundayo (orforglipron), the first oral GLP-1 weight-loss pill, arrived in April 2026 with no needles, no fasting restrictions, and clinical trial results showing 27.3 pounds of average weight loss. Here's what it means for patients, healthcare, and the ethics of obesity treatment.